C07D 233/74
With only hydrogen atoms or radicals containing only hydrogen and carbon atoms
Official title: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
C07D233/74 (With only hydrogen atoms or radicals containing only hydrogen and carbon atoms) appears on 219 US grants and 144 published applications in this corpus.
Search patents in C07D- Granted patents
- 219
- Published applications
- 144
- Assignees
- 145
- Inventors
- 636
- Latest grant
- 17 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 1 | 0 |
| 1978 | 7 | 0 |
| 1979 | 7 | 0 |
| 1980 | 11 | 0 |
| 1981 | 5 | 0 |
| 1982 | 4 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 4 | 0 |
| 1986 | 2 | 0 |
| 1987 | 6 | 0 |
| 1988 | 2 | 0 |
| 1989 | 4 | 0 |
| 1990 | 2 | 0 |
| 1991 | 6 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 6 | 0 |
| 1995 | 6 | 0 |
| 1996 | 3 | 0 |
| 1997 | 11 | 0 |
| 1998 | 4 | 0 |
| 1999 | 6 | 0 |
| 2000 | 7 | 0 |
| 2001 | 7 | 1 |
| 2002 | 8 | 4 |
| 2003 | 3 | 16 |
| 2004 | 5 | 8 |
| 2005 | 4 | 2 |
| 2006 | 7 | 5 |
| 2007 | 0 | 4 |
| 2008 | 3 | 1 |
| 2009 | 0 | 5 |
| 2010 | 4 | 10 |
| 2011 | 6 | 7 |
| 2012 | 4 | 5 |
| 2013 | 7 | 5 |
| 2014 | 1 | 3 |
| 2015 | 4 | 5 |
| 2016 | 2 | 4 |
| 2017 | 5 | 5 |
| 2018 | 5 | 7 |
| 2019 | 2 | 9 |
| 2020 | 8 | 5 |
| 2021 | 7 | 7 |
| 2022 | 1 | 7 |
| 2023 | 5 | 4 |
| 2024 | 5 | 8 |
| 2025 | 2 | 4 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Polymeric disinfectants and uses thereof17 Feb 2026US 12,552,882 B2Technion Research & Development Foundation Limited
- Matrix metalloproteinase (MMP) inhibitors and methods of use thereof25 Mar 2025US 12,258,335 B1Foresee Pharmaceuticals USA, Inc.
- Matrix metalloproteinase (MMP) inhibitors and methods of use thereof4 Feb 2025US 12,215,096 B2Foresee Pharmaceuticals USA, Inc.
- Peripheral alkyl and alkenyl chains extended benzene derivatives and pharmaceutical composition including the same10 Dec 2024US 12,162,820 B2Taiwanj Pharmaceuticals Co., Ltd.
- Hydantoin containing deoxyuridine triphosphatase inhibitors24 Sep 2024US 12,098,133 B2CV6 Therapeutics (NI) Limited
- Matrix metalloproteinase (mmp) inhibitors and methods of use thereof10 Sep 2026US 2026/0265232 A1Foresee Pharmaceuticals USA, Inc.
- Therapy based on synthetic lethality in swi/snf complex-dysfunction cancer27 Aug 2026US 2026/0248806 A1National Cancer Center
- N-(benzhydryl)cycloalkylcarboxamide derivatives as inhibitors of glycogen synthase 1 (gys1) and methods of use thereof26 Mar 2026US 2026/0085034 A1Maze Therapeutics, Inc.
- Diarylhydantoin compounds30 Oct 2025US 2025/0333385 A1The Regents of the University of California
- Rxfp1 agonists10 Jul 2025US 2025/0221966 A1Bristol-Myers Squibb Company
Most cited
By later US patents
- Pharmaceutical formulations for parenteral use208US 5,024,998 AUniversity of Florida · 1991
- Androgenic directed compositions95US 5,656,651 ABiophysica, Inc. · 1997
- Pharmaceutical formulations for parenteral use93US 4,983,586 AUniversity of Florida · 1991
- Phenylimidazolidines having antiandrogenic activity85US 5,411,981 ARoussel Uclaf · 1995
- Benzothiepin derivatives, process for the preparation of the same and uses thereof72US 6,355,672 B1Takeda Chemical Industries, Ltd. · 2002